Development of a novel, quantitative assay for determining the rate of activity of antimalarial drugs
Malaria, caused by an intracellular Plasmodium parasite, remains a devastating disease, having claimed approximately 655 000 lives worldwide in 2010. The Medicines for Malaria Venture suggests a "single-dose radical cure" as the ideal malaria treatment since rapid clearance of blood-stage...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Rhodes University
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10962/d1001618 |